Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.49
-0.01 (-2.91%)
At close: Aug 19, 2025, 3:58 PM

Harvard Bioscience Revenue

Harvard Bioscience reported an annual revenue of $94.14M, reflecting a -16.14% growth. For the quarter ending June 30, 2025, Harvard Bioscience generated $20.45M in revenue.
Revenue (ttm)
94.14M
Revenue Growth
-16.14%
Price / Sales Ratio
0.98
Revenue / Employee
285.26K
Employees
330
Market Cap
21.92M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 94.14M -16.14%
Dec 31, 2023 112.25M -0.96%
Dec 31, 2022 113.33M -4.68%
Dec 31, 2021 118.9M +16.46%
Dec 31, 2020 102.1M -12.12%
Dec 31, 2019 116.18M -3.81%
Dec 31, 2018 120.77M +18.54%
Dec 31, 2017 101.88M -2.52%
Dec 31, 2016 104.52M -3.81%
Dec 31, 2015 108.66M +0.00%
Dec 31, 2014 108.66M +3.32%
Dec 31, 2013 105.17M -5.40%
Dec 31, 2012 111.17M +2.12%
Dec 31, 2011 108.86M +0.63%
Dec 31, 2010 108.18M +26.12%
Dec 31, 2009 85.77M -2.59%
Dec 31, 2008 88.05M +5.57%
Dec 31, 2007 83.41M +9.49%
Dec 31, 2006 76.18M +12.98%
Dec 31, 2005 67.43M -27.18%
Dec 31, 2004 92.6M +6.26%
Dec 31, 2003 87.14M +51.87%
Dec 31, 2002 57.38M +40.40%
Dec 31, 2001 40.87M +33.67%
Dec 31, 2000 30.57M +16.80%
Dec 31, 1999 26.18M +115.38%
Dec 31, 1998 12.15M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.